Stanford University


Showing 501-550 of 828 Results

  • Jan Skotheim

    Jan Skotheim

    Professor of Biology and, by courtesy, of Chemical and Systems Biology

    Current Research and Scholarly InterestsMy overarching goal is to understand how cell growth triggers cell division. Linking growth to division is important because it allows cells to maintain specific size range to best perform their physiological functions. For example, red blood cells must be small enough to flow through small capillaries, whereas macrophages must be large enough to engulf pathogens. In addition to being important for normal cell and tissue physiology, the link between growth and division is misregulated in cancer.

  • Irina Skylar-Scott

    Irina Skylar-Scott

    Clinical Assistant Professor, Neurology & Neurological Sciences

    BioDr. Skylar-Scott is a board-certified, fellowship-trained cognitive and behavioral neurologist and clinical assistant professor at Stanford University. She is a Diplomate of the American Board of Psychiatry and Neurology as well as the United Council for Neurologic Subspecialties in Behavioral Neurology and Neuropsychiatry.

    Her clinical interests include the treatment of cognitive and behavioral impairment due to Alzheimer’s disease, Parkinson’s disease, Lewy body dementia, posterior cortical atrophy, primary progressive aphasia, frontotemporal dementia, vascular dementia, primary age-related tauopathy, and limbic-predominant age-associated TDP-43 encephalopathy, among other disorders of cognition and behavior.

    Her research interests include clinical trials for Alzheimer’s disease and how social and intellectual engagement can affect cognition. She has also investigated impaired consciousness in epilepsy and biomarkers for assessing Duchenne muscular dystrophy. Prior to joining Stanford, Dr. Skylar-Scott was a fellow in the Center for Alzheimer’s Research and Treatment (CART) in the Department of Neurology at Harvard Medical School/Brigham and Women’s Hospital. She also completed her undergraduate degree at MIT, her MD at Yale, and her residency at Harvard.

    Dr. Skylar-Scott’s work has appeared in Neurology, Alzheimer's Research and Therapy, Pediatric Neurology, the Journal of Ultrasound in Medicine, Muscle & Nerve, and Epilepsia. She also has also been invited to write book chapters on Alzheimer’s disease, normal pressure hydrocephalus, Parkinson’s disease dementia and Lewy body dementia, and the cognitive and psychiatric consequences of neuroimmunological disorders published by Elsevier and McGraw-Hill.

    Presentations by Dr. Skylar-Scott have focused on prevention of cognitive decline in at-risk elderly people, cognitive and neuropsychiatric manifestations of Parkinson’s disease, human prion diseases, and other topics. She has presented at meetings held by the American Academy of Neurology (AAN), the American Neurological Association (ANA), and the American Academy of Neuromuscular and Electrodiagnostic Medicine (AANEM).

    For her research and scholarship, Dr. Skylar-Scott has earned honors from the American Academy of Neurology (AAN) and the Howard Hughes Medical Institute (HHMI). She was honored to receive the Golseth Young Investigator Award from the American Association of Neuromuscular & Electrodiagnostic Medicine. In addition, she won the Action Duchenne International Conference First Prize Poster for her research in Duchenne muscular dystrophy.

    Dr. Skylar-Scott is a member of the American Neurological Association and American Academy of Neurology. Every year, she walks to raise money for Alzheimer's disease and Lewy body dementia.

  • Kristen M. Slater, PsyD

    Kristen M. Slater, PsyD

    Clinical Assistant Professor, Anesthesiology, Perioperative and Pain Medicine

    Bio“Understanding and appreciating the totality of a person’s experience in the context of a difficult pain condition is vital in helping them heal in a way that respects their body and reduces suffering” states Dr. Kristen Slater, pain psychologist. “With a compassionate interdisciplinary care team in place, I wholeheartedly believe it is possible for anyone and everyone living with pain to pursue a meaningful and valuable life.”

    Dr. Kristen Slater earned her Doctorate of Psychology with an emphasis in Behavioral Medicine and Health Psychology from Loma Linda University. She completed her APA-accredited internship at the Southern Arizona VA Health Care System in Tucson, Arizona. It was there that she developed a passion for Pain Medicine after appreciating how much of an impact pain can have in all areas of life and how powerful interdisciplinary treatment of pain can be in improving one’s quality of life. She went on to receive specialized postdoctoral training and completed an APA-accredited Fellowship in Pain Psychology at Stanford University School of Medicine in the Department of Anesthesiology, Division of Pain, in 2014.

    Following her training, she was hired as the lead psychologist and Director of Behavioral Medicine and Psychological Services at Comprehensive Spine and Sports Center in Campbell, California for 5 years where she helped create and found their Functional Restoration Program and Pain Psychology Program. She also worked part-time as a Clinical Instructor at Stanford University School of Medicine and in private practice. She transitioned to Stanford full time in 2019 and is currently a Clinical Assistant Professor in the Department of Anesthesiology and Perioperative Pain Medicine. The majority of her time is allocated towards implementing evidence-based clinical practices but she also enjoys being involved in advancing the field through research. She is involved in multiple NIH and PCORI funded clinical trials working to enhance treatment efficacy and accessibility. She is also a faculty member of the "Empowered Relief" team, and is a Master Trainer involved in teaching international workshops to train clinicians to deliver the single-session evidence-based pain relief skills class, (https://empoweredrelief.com).

    Outside of work, Dr. Slater enjoys spending time with her family. She enjoys hiking, traveling and visiting her home state of Colorado.

  • Norman Sleep

    Norman Sleep

    Professor of Geophysics, Emeritus

    Current Research and Scholarly InterestsPhysics of large-scale processes in the Earth

  • Maggi Smeal MD

    Maggi Smeal MD

    Clinical Instructor, Pediatrics - General Pediatrics

    BioMaggi Smeal MD does her clinical work at Gardner Packard Children's Health Care supervising Stanford residents and medical students in urgent care. She is co-director of the Families at the Border Program in Stanford's Center for Innovation in Global Health. Her humanitarian aid work is focused on helping asylum-seeking families in Tijuana who access care at the Refugee Health Alliance clinics ( RHA) . She leads a team of pediatricians, medical students, undergraduate students and community members to support RHA. The team has taught Helping Babies Breathe, a low-resource neonatal resuscitation program, to midwives in Tijuana. She has also brought a Pediatric Emergency Readiness course to providers at RHA clinics and supports the clinic through telemedicine. She is also a member of RHA's pediatric committee. Her global health work has also involved humanitarian aid in the Philippines and Peru. Locally she has worked on mobile health vans to support migrant farm workers and provided educational sessions for clients at LifeMoves Homeless Shelters. Her team's work with Families at the Border has been presented at the Consortium of Universities for Global Health National Conference and the group was awarded the Untold Global Health Story of 2020.

  • Grant M. Smith, MD

    Grant M. Smith, MD

    Clinical Assistant Professor, Medicine - Primary Care and Population Health

    BioDr. Grant Smith is a palliative care physician and Clinical Assistant Professor of Medicine at the Stanford School of Medicine. He is the medical director of the Stanford Palliative Care Center of Excellence (PCCOE) Community Partnerships Team, and he is the lead for quality improvement in advance care planning in the Division of Primary Care and Population Health. Dr. Smith graduated with a Bachelor of Science in psychology from Duke University. He received his medical degree from Harvard Medical School. He completed residency in internal medicine at the University of California, San Francisco with a focus in primary care, followed by a chief resident year at the Zuckerberg San Francisco General Hospital. He subsequently completed his palliative care fellowship at the University of California, San Francisco. As part of the Stanford faculty, he is an attending on the palliative care inpatient service and as a provider in the outpatient palliative care clinic in Palo Alto.

  • Julius Smith

    Julius Smith

    Professor of Music, Emeritus

    BioSmith is a professor emeritus of music and (by courtesy) electrical engineering (Information Systems Lab) based at the Center for Computer Research in Music and Acoustics (CCRMA). Teaching and research pertain to music and audio applications of signal processing. Former software engineer at NeXT Computer, Inc., responsible for signal processing software pertaining to music and audio. For more, see https://ccrma.stanford.edu/~jos/.

  • Kendric C. Smith

    Kendric C. Smith

    Professor of Radiation Oncology, Emeritus

    Current Research and Scholarly InterestsThe photochemistry and radiation chemistry of DNA, the genetic control and biochemical bases of the multiple pathways of DNA repair, and the roles of DNA repair processes in radiation and spontaneous mutagenesis. Over 190 papers have been published on these and related topics.

  • Mark Smith

    Mark Smith

    Head of Medicinal Chemistry

    BioDr. Mark Smith joined Stanford ChEM-H in May 2013 as the Head of the Medicinal Chemistry Knowledge Center. He graduated with a Ph.D. from the laboratory of Prof. Richard Stoodley at the University of Manchester Institute for Science and Technology (UMIST), where his research focused on the application of Lewis acid catalyzed hetero Diels-Alder reactions to the synthesis of novel disaccharide structures. In 2000, Dr. Smith joined the research laboratory of Prof. David Crich at the University of Illinois at Chicago. Here his research focused on the generation of new reagents for the synthesis of beta-mannosides from thioglycosides. From 2002 to 2013, Dr. Smith worked as a medicinal chemist in Roche’s research facilities both in Palo Alto, CA and then Nutley, NJ, where he specialized in antiviral research.

  • Matthew Smith

    Matthew Smith

    Professor of German Studies and of Theater and Performance Studies

    BioMatthew Wilson Smith’s interests include modern theatre and relations between science, technology, and the arts. His book The Nervous Stage: 19th-century Neuroscience and the Birth of Modern Theatre (Oxford, 2017) explores historical intersections between theatre and neurology and traces the construction of a “neural subject” over the course of the nineteenth century. It was a finalist for the George Freedley Memorial Award of the Theater Library Association. His previous book, The Total Work of Art: From Bayreuth to Cyberspace (Routledge, 2007), presents a history and theory of attempts to unify the arts; the book places such diverse figures as Wagner, Moholy-Nagy, Brecht, Riefenstahl, Disney, Warhol, and contemporary cyber-artists within a coherent genealogy of multimedia performance. He is the editor of Georg Büchner: The Major Works, which appeared as a Norton Critical Edition in 2011, and the co-editor of Modernism and Opera (Johns Hopkins, 2016), which was shortlisted for an MSA Book Prize. His essays on theater, opera, film, and virtual reality have appeared widely, and his work as a playwright has appeared at the Eugene O’Neill Musical Theater Conference, Richard Foreman’s Ontological-Hysteric Theater, and other stages. He previously held professorships at Cornell University and Boston University as well as visiting positions at Columbia University and Johannes Gutenberg-Universität (Mainz).

  • Melody Smith, MD, MS

    Melody Smith, MD, MS

    Assistant Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)

    BioDr. Smith is a board-certified, fellowship-trained medical oncologist and hematologist. She is an assistant professor in the Department of Medicine in the Division of Blood & Marrow Transplantation and Cellular Therapy.

    She is also a physician-scientist who conducts extensive research. As a medical student, she completed a fellowship at the National Institutes of Health (NIH) in the Clinical Research Training (now, the Medical Research Scholars) Program. Subsequently, following her clinical fellowship, she was a post-doctoral researcher at Memorial Sloan Kettering Cancer Center. The research in her lab focuses on investigations of the biology of chimeric antigen receptor (CAR) T cells to improve the efficacy and safety of this therapy (1) by investigating donor (Nature Medicine, 2017) and off-the-shelf CAR T cells in mouse models and (2) by assessing mechanisms for the impact of the intestinal microbiome on CAR T cell response (Nature Medicine, 2022).

    Dr. Smith presents the findings of her research at regional, national, and international conferences. Further, she has co-authored articles on topics within the field of cancer immunology, including cancer immunotherapy, stem cell transplantation, and CAR T cell therapy. Her work has appeared in journals, among others Nature, Nature Immunology, Nature Medicine, Blood, and Transplantation and Cellular Therapy. She serves a peer reviewer for publications in journals, such as NEJM Evidence, Science Advances, Blood, Cancer Cell, and Molecular Therapy. She also has contributed to chapters in books, including Pocket Oncology, Current Concepts and Controversies in Hematopoietic Cell Transplantation, and Advanced Concepts in Human Immunology: Prospects for Disease Control.

    She has earned numerous honors; the American Society of Hematology (ASH), the Society for Immunotherapy of Cancer, the European Society for Blood and Marrow Transplantation, and several other professional organizations have recognized her achievements as a clinician, researcher, and scholar.

    Dr. Smith is a member of the ASH Committee on Emerging Gene and Cell Therapies and the ASH Committee on Diversity, Equity & Inclusion. Additionally, she serves on committees within the institution and professional organizations focused on promoting diversity among hematology and cell therapy specialists.

  • Robert Lane Smith

    Robert Lane Smith

    Professor (Research) of Orthopedic Surgery, Emeritus

    Current Research and Scholarly InterestsOur group is interested in the molecular and cell biology underlying bone and cartilage metabolism in health and disease. Normal daily activities are linked to the ability of the articular cartilage to withstand normal joint forces that may reach 5-7 times body weight and bone homeostasis depends on daily mechanical loading histories.

  • Stephanie Melissa Smith

    Stephanie Melissa Smith

    Instructor, Pediatrics - Hematology & Oncology

    Current Research and Scholarly InterestsI am involved with clinical research related to cancer survivorship, with a particular focus on late effects of childhood cancer treatments and community partnerships to improve health equity for adolescent/young adult cancer survivors in under-resourced settings.

  • Stephen J Smith

    Stephen J Smith

    Professor of Molecular and Cellular Physiology, Emeritus

    Current Research and Scholarly InterestsStephen Smith remains active in the computational microscopy field and is also currently using data science tools to explore new transcriptomic perspectives on signaling by neuropeptides and other neuromodulators in brains of diverse animal species. These exploration have unearthed evidence for a previous unrecognized ubiquity of local neuropeptide signaling and possible critical involvement of such signaling in memory engram formation.

  • Stephen Smith, MD

    Stephen Smith, MD

    Clinical Assistant Professor, Ophthalmology

    Current Research and Scholarly InterestsRESEARCH OVERVIEW

    Dr. Smith’s primary professional interest is developing solutions for unmet clinical and surgical vitreoretinal needs. Beginning in medical school, one of his primary focuses has been improving treatment outcomes in patients with retinoblastoma (RB). During his second year in medical school Dr. Smith published a manuscript on a novel technique to reduce the risk of tumor spread following intravitreal drug delivery in patients with RB. His work summarizing published data on tumor spread following intravitreal injection therapy (IVT) for RB has resulted in multiple platform presentations at national and international meetings, including an invited lecture at ARVO 2014. The results of this study influenced the growing trend toward broader acceptance of intravitreal chemotherapy in pediatric patients with treatment-resistant retinoblastoma vitreous seeds. A primary active area of research has included studying and publishing on ocular toxicity that results from the use of intravitreal melphalan and other agents for RB. This work, and subsequent publications from leaders in the field, has led to an increased awareness of ocular toxicity caused by injecting chemotherapeutic agents into the eyes of young children. This highlighted the need for toxicity data on additional chemotherapeutic agents for local delivery. To answer this question, Dr. Smith assembled an excellent group of collaborators and consultants, including internationally known experts at Bascom Palmer, Mayo Clinic, and Emory University. As a resident he secured a highly competitive career starter grant from the Knights Templar Foundation and used that funding and the expertise of his collaborators to carry out preclinical ocular toxicity studies of combination intravitreal chemotherapy for RB. His work in RB has led to a broader recognition of the challenges facing patients with RB who receive IVT and has led to a continued search for optimal local injectable therapies for patients with this disease.


    INNOVATION HIGHLIGHTS

    In addition to his work in retinoblastoma, Dr. Smith has been actively involved in developing technologies to improve outcomes for patients receiving intravitreal injection therapy (IVT) for macular degeneration, diabetic retinopathy, retinal vein occlusions and more. IVT has become the most common procedure performed by retina specialists in the United States, with an estimated 6 million injections given in the United States alone in 2016. Dr. Smith has co-developed technology that simplifies and streamlines the IVT process, removing barriers to treatment and improving patient outcomes. His work in innovation covers pre-clinical and clinical development work, and has given him expertise in diverse subject areas including fundraising, intellectual property portfolio development, team building, and business administration. He is a co-founder of iRenix Medical, a biotechnology and medical device start-up company committed to improving vision through optimization of the IVT process.

    Dr. Smith remains dedicated to helping improve and restore vision and quality of life in patients with vitreoretinal disease. He is currently involved in both medical device and pharmaceutical innovation, and serves as a mentor for the Stanford University Biodesign Innovation Course.

  • Todd Smith

    Todd Smith

    Professor (Research) of Physics, Emeritus

    BioTodd received his PhD from Rice University. He acted as an assistant professor of physics and electrical engineering, senior research physicist, and professor of physics. Research interests include experimental accelerator physics, laser physics, and superconductivity. His specialty is free electron lasers.

  • Rebecca Smith-Coggins, MD

    Rebecca Smith-Coggins, MD

    Professor (Teaching) of Emergency Medicine, Emerita

    Current Research and Scholarly InterestsEffect of work schedule on work performance, mood and, sleep architecture in attending emergency medicine physicians,residents.

  • Matthew Smuck, MD

    Matthew Smuck, MD

    Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsI direct the Wearable Health Lab at Stanford, investigating medical applications of mobile technology to improve musculoskeletal and neurologic disease detection, treatment and prevention.

  • Paul Sniderman

    Paul Sniderman

    Fairleigh S. Dickinson, Jr. Professor of Public Policy

    BioPaul M. Sniderman is the Fairleigh S. Dickinson Jr. Professor in Public Policy.

    Sniderman’s research focuses on multiculturalism and politics in Western Europe and spatial reasoning.

    He coauthored The Struggle for Inclusion: Muslims and Liberal Democracy (University of Chicago Press, 2020) with Elisabeth Ivarsflaten.

    He has published many other books, including When Ways of Life Collide: Multiculturalism and Its Discontents in the Netherlands (Princeton University Press, 2007) with Louk Hagendoorn, Reasoning and Choice, The Scar of Race, Reaching beyond Race, The Outsider, and Black Pride and Black Prejudice, in addition to a plethora of articles. He initiated the use of computer-assisted interviewing to combine randomized experiments and general population survey research.

    A fellow of the American Academy of Arts and Sciences and of the American Association for the Advancement of Science, he has been awarded the Woodrow Wilson Prize, 1992; the Franklin L. Burdette Pi Sigma Alpha Award, 1994; an award for the Outstanding Book on the Subject of Human Rights from the Gustavus Meyers Center, 1994; the Gladys M. Kammerer Award, 1998; the Pi Sigma Alpha Award; and the Ralph J. Bunche Award, 2003.

    Sniderman received his B.A. degree (philosophy) from the University of Toronto and his M.A. and Ph.D. degrees from the University of California, Berkeley.

  • C. Matthew Snipp

    C. Matthew Snipp

    Vice Provost for Student Affairs, Vice Provost for Faculty Development, Diversity and Engagement and Burnet C. and Mildred Finley Wohlford Professor

    BioC. Matthew Snipp is the Burnet C. and Mildred Finley Wohlford Professor of Humanities and Sciences in the Department of Sociology at Stanford University. He is also the Director for the Institute for Research in the Social Science’s Secure Data Center and formerly directed Stanford’s Center for the Comparative Study of Race and Ethnicity (CCSRE). Before moving to Stanford in 1996, he was a Professor of Sociology at the University of Wisconsin -- Madison. He has been a Research Fellow at the U.S. Bureau of the Census and a Fellow at the Center for Advanced Study in the Behavioral Sciences. Professor Snipp has published 3 books and over 70 articles and book chapters on demography, economic development, poverty and unemployment. His current research and writing deals with the methodology of racial measurement, changes in the social and economic well-being of American ethnic minorities, and American Indian education. For nearly ten years, he served as an appointed member of the Census Bureau’s Racial and Ethnic Advisory Committee. He also has been involved with several advisory working groups evaluating the 2000 census, three National Academy of Science panels focused on the 2010 and 2020 censuses. He also has served as a member of the Board of Scientific Counselors for the Centers for Disease Control and the National Center for Health Statistics as well as an elected member of the Inter-University Consortium of Political and Social Research’s Council. He is currently serving on the National Institute of Child Health and Development’s Population Science Subcommittee. Snipp holds a Ph.D. in Sociology from the University of Wisconsin—Madison.

  • Michael Snyder, Ph.D.

    Michael Snyder, Ph.D.

    Stanford W. Ascherman Professor of Genetics

    Current Research and Scholarly InterestsOur laboratory use different omics approaches to study a) regulatory networks, b) intra- and inter-species variation which differs primarily at the level of regulatory information c) human health and disease. For the later we have established integrated Personal Omics Profiling (iPOP), an analysis that combines longitudinal analyses of genomic, transcriptomic, proteomic, metabolomic, DNA methylation, microbiome and autoantibody profiles to monitor healthy and disease states

  • Samuel So, MD

    Samuel So, MD

    Lui Hac Minh Professor in the School of Medicine
    On Partial Leave from 06/17/2024 To 07/17/2024

    Current Research and Scholarly InterestsThrough a 4 pronged comprehensive program: translational and clinical research, early detection and treatment, promoting education, awareness and immunization and building partnership, we are working towards the development of new strategies that will lead to the elimination of hepatitis B worldwide and reduce the threat and incidence of liver cancer. Current research efforts focus on evaluating potential new diagnostic and treatment markers and novel targeted therapy for primary liver cancer.

  • Yuen So, MD, PhD

    Yuen So, MD, PhD

    Professor of Neurology (Adult Neurology)
    On Partial Leave from 02/01/2024 To 08/18/2024

    Current Research and Scholarly InterestsResearch in the diagnosis, pathophysiology and treatment of peripheral neuropathy, myasthenia gravis, motor neuron diseases including ALS and SMA, nerve injuries and muscle diseases. Application of clinical neurophysiological methods to neurological diagnosis. Development of evidence-based medicine pertaining to the practice of neurology.

  • Raymond A. Sobel, M.D.

    Raymond A. Sobel, M.D.

    Professor of Pathology

    Current Research and Scholarly InterestsWe study cellular and molecular mechanisms of immune-mediated injury in CNS tissues that are affected in multiple sclerosis (MS). We study: 1) tissues of mice with EAE using histology and immunohistochemistry, 2) cross-recognition of neurons by antibodies against myelin proteolipid protein epitopes, and a distinct oligodendrogliopathy induced in mice by the non-protein amino acid azetidine (Aze), (which is found in the human diet); Aze-induced abnormalities mimic those in MS patient CNS tissues

  • Hyongsok Tom  Soh

    Hyongsok Tom Soh

    Professor of Radiology (Early Detection), of Electrical Engineering, of Bioengineering and, by courtesy, of Chemical Engineering

    BioDr. Soh received his B.S. with a double major in Mechanical Engineering and Materials Science with Distinction from Cornell University and his Ph.D. in Electrical Engineering from Stanford University. From 1999 to 2003, Dr. Soh served as the technical manager of MEMS Device Research Group at Bell Laboratories and Agere Systems. He was a faculty member at UCSB before joining Stanford in 2015. His current research interests are in analytical biotechnology, especially in high-throughput screening, directed evolution, and integrated biosensors.

  • Lynn Sokei

    Lynn Sokei

    Lecturer

    BioLynn Sokei holds a PhD in English from the University of Colorado at Boulder and an MFA in Fiction from Arizona State University.